Kura Oncology (NASDAQ: KURA) CEO buys more in 100,000-share insider trade
Rhea-AI Filing Summary
Kura Oncology, Inc. director and President and CEO Troy Edward Wilson reported a purchase of 100,000 shares of Common Stock on 2026-08-17 at a weighted average price of $11.12 per share, executed in multiple trades between $10.87 and $11.31. The purchased shares are held indirectly by One Fish Two Fish Revocable Trust, bringing that trust’s reported holdings to 379,194 shares following the transaction. Additional reported positions include 300,000 shares held indirectly by Lorax Charitable Remainder Unitrust and 435,456 shares held directly by the reporting person.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 100,000 shares
Net Buy
3 txns
Insider
WILSON TROY EDWARD
Role
President and CEO
Bought
100,000 shs ($1.11M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 100,000 | $11.12 | $1.11M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 379,194 shares (Indirect, by One Fish Two Fish Revocable Trust);
Common Stock — 300,000 shares (Indirect, by Lorax Charitable Remainder Unitrust);
Common Stock — 435,456 shares (Direct)
Footnotes (1)
- F1. This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares purchased: 100,000 shares
Weighted average purchase price: $11.12 per share
Price range of trades: $10.87–$11.31 per share
+3 more
6 metrics
Shares purchased
100,000 shares
Common Stock purchased on 2026-08-17 in open market or private transactions
Weighted average purchase price
$11.12 per share
Weighted average price for the 100,000-share purchase, trades from $10.87 to $11.31
Price range of trades
$10.87–$11.31 per share
Range of prices for multiple trades comprising the reported 100,000-share purchase
Indirect holdings – One Fish Two Fish Revocable Trust
379,194 shares
Total Kura Oncology common shares held indirectly by this trust after the purchase
Indirect holdings – Lorax Charitable Remainder Unitrust
300,000 shares
Kura Oncology common shares held indirectly by Lorax Charitable Remainder Unitrust
Direct holdings
435,456 shares
Kura Oncology common shares held directly by Troy Wilson as reported
Key Terms
weighted average purchase price, revocable trust, Charitable Remainder Unitrust
3 terms
weighted average purchase price financial
"The price reported above reflects the weighted average purchase price."
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
revocable trust financial
"direct_or_indirect: I, nature_of_ownership: by One Fish Two Fish Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Charitable Remainder Unitrust financial
"nature_of_ownership: by Lorax Charitable Remainder Unitrust"
FAQ
What insider transaction did KURA CEO Troy Wilson report on this Form 4?
Troy Wilson reported a purchase of 100,000 Kura Oncology (KURA) common shares on 2026-08-17 at a weighted average price of $11.12 per share, executed in multiple trades between $10.87 and $11.31.
What are Troy Wilson’s other reported indirect Kura Oncology (KURA) holdings?
In addition to the One Fish Two Fish Revocable Trust, Troy Wilson reports 300,000 KURA shares held indirectly by Lorax Charitable Remainder Unitrust, as of the same reporting date, separate from his direct share ownership.
Was Troy Wilson’s Kura Oncology (KURA) stock purchase under a Rule 10b5-1 plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirming a trading plan, and the footnote does not reference any such plan for the 100,000-share KURA purchase.
AI-generated analysis. How Rhea-AI works. Not financial advice.
